Comment on “Analysis of Pharmacokinetic and Pharmacodynamic Parameters in EU-Versus US-Licensed Reference Biological Products: Are In Vivo Bridging Studies Justified for Biosimilar Development?”
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-190X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Comment on “Analysis of Pharmacokinetic and Pharmacodynamic Parameters in EU-Versus US-Licensed Reference Biological Products: Are In Vivo Bridging Studies Justified for Biosimilar Development?” ; volume:33 ; number:5 ; day:1 ; month:8 ; year:2019 ; pages:581-582 ; date:10.2019
BioDrugs ; 33, Heft 5 (1.8.2019), 581-582, 10.2019
- Creator
-
Webster, Christopher J.
Woollett, Gillian R.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40259-019-00372-3
- URN
-
urn:nbn:de:101:1-2020013012314481715589
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Webster, Christopher J.
- Woollett, Gillian R.
- SpringerLink (Online service)
Other Objects (12)
Population pharmacokinetic, pharmacodynamic and efficacy modeling of SB12 (proposed eculizumab biosimilar) and reference eculizumab
The first biosimilar approved for the treatment of osteoporosis: results of a comparative pharmacokinetic/pharmacodynamic study
Apixaban: A Clinical Pharmacokinetic and Pharmacodynamic Review
A Population Pharmacokinetic-Pharmacodynamic Model of Pegfilgrastim
Clinical Pharmacokinetic and Pharmacodynamic Profile of Vericiguat
Clinical Pharmacokinetic and Pharmacodynamic Profile of Riociguat
Pharmacokinetic/pharmacodynamic evaluation of gamithromycin against rabbit pasteurellosis
A pharmacokinetic-pharmacodynamic assessment of oral antibiotics for pyelonephritis
Optimal designs for composed models in pharmacokinetic-pharmacodynamic experiments
Population Pharmacokinetic and Pharmacokinetic/Pharmacodynamic Analyses of Pegcetacoplan in Patients with Paroxysmal Nocturnal Hemoglobinuria
Pharmacokinetic-pharmacodynamic modeling of tylosin against Streptococcus suis in pigs
Amikacin pharmacokinetic/pharmacodynamic in intensive care unit: a prospective database
Population pharmacokinetic, pharmacodynamic and efficacy modeling of SB12 (proposed eculizumab biosimilar) and reference eculizumab
The first biosimilar approved for the treatment of osteoporosis: results of a comparative pharmacokinetic/pharmacodynamic study
Apixaban: A Clinical Pharmacokinetic and Pharmacodynamic Review
A Population Pharmacokinetic-Pharmacodynamic Model of Pegfilgrastim
Clinical Pharmacokinetic and Pharmacodynamic Profile of Vericiguat
Clinical Pharmacokinetic and Pharmacodynamic Profile of Riociguat
Pharmacokinetic/pharmacodynamic evaluation of gamithromycin against rabbit pasteurellosis
A pharmacokinetic-pharmacodynamic assessment of oral antibiotics for pyelonephritis
Optimal designs for composed models in pharmacokinetic-pharmacodynamic experiments
Population Pharmacokinetic and Pharmacokinetic/Pharmacodynamic Analyses of Pegcetacoplan in Patients with Paroxysmal Nocturnal Hemoglobinuria
Pharmacokinetic-pharmacodynamic modeling of tylosin against Streptococcus suis in pigs
Amikacin pharmacokinetic/pharmacodynamic in intensive care unit: a prospective database
Population pharmacokinetic, pharmacodynamic and efficacy modeling of SB12 (proposed eculizumab biosimilar) and reference eculizumab
The first biosimilar approved for the treatment of osteoporosis: results of a comparative pharmacokinetic/pharmacodynamic study
Apixaban: A Clinical Pharmacokinetic and Pharmacodynamic Review
A Population Pharmacokinetic-Pharmacodynamic Model of Pegfilgrastim
Clinical Pharmacokinetic and Pharmacodynamic Profile of Vericiguat
Clinical Pharmacokinetic and Pharmacodynamic Profile of Riociguat
Pharmacokinetic/pharmacodynamic evaluation of gamithromycin against rabbit pasteurellosis
A pharmacokinetic-pharmacodynamic assessment of oral antibiotics for pyelonephritis
Optimal designs for composed models in pharmacokinetic-pharmacodynamic experiments
Population Pharmacokinetic and Pharmacokinetic/Pharmacodynamic Analyses of Pegcetacoplan in Patients with Paroxysmal Nocturnal Hemoglobinuria
Pharmacokinetic-pharmacodynamic modeling of tylosin against Streptococcus suis in pigs